| |
2003
|
2004
|
2005
|
2006
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
Total
|
|---|
|
No diabetes
|
|
N
|
424
|
479
|
589
|
652
|
766
|
835
|
1119
|
1257
|
1334
|
1379
|
8834
|
|
Incidence*
|
4.07
|
4.82
|
5.16
|
6.06
|
6.43
|
8.4
|
9.44
|
9.75
|
10.07
|
7.12
|
6.9
|
|
Age, mean* (SD)
|
72.08 (7.97)
|
73.11 (7.75)
|
72.55 (8.02)
|
73.31 (7.51)
|
73.56 (8.15)
|
73.58 (7.74)
|
73.65 (7.94)
|
73.99 (7.86)
|
73.85 (7.75)
|
73.68 (7.7)
|
73.51 (7.84)
|
|
Male, n (%)*
|
410 (96.7)
|
458 (95.62)
|
572 (97.11)
|
631 (96.78)
|
725 (94.65)
|
792 (94.85)
|
1052 (94.01)
|
1191 (94.75)
|
1261 (94.53)
|
1299 (94.2)
|
8391 (94.99)
|
|
CCI 0–1, n (%)
|
250 (58.96)
|
240 (50.1)
|
279 (47.37)
|
348 (53.37)
|
398 (51.96)
|
417 (49.94)
|
588 (52.55)
|
635 (50.52)
|
718 (53.82)
|
732 (53.08)
|
4605 (52.13)
|
|
CCI 2, n (%)
|
131 (30.9)
|
163 (34.03)
|
212 (35.99)
|
216 (33.13)
|
263 (34.33)
|
303 (36.29)
|
383 (34.23)
|
455 (36.2)
|
451 (33.81)
|
453 (32.85)
|
3030 (34.30)
|
|
CCI ≥3, n (%)
|
43 (10.14)
|
76 (15.87)
|
98 (16.64)
|
88 (13.5)
|
105 (13.71)
|
115 (13.77)
|
148 (13.23)
|
167 (13.29)
|
165 (12.37)
|
194 (14.07)
|
1190 (13.57)
|
|
Smoking*
|
151 (35.61)
|
192 (40.08)
|
222 (37.69)
|
246 (37.73)
|
288 (37.6)
|
346 (41.44)
|
451 (40.3)
|
528 (42)
|
562 (42.13)
|
611 (44.31)
|
3597 (40.72)
|
|
LOSH, mean (SD)*
|
8 (10)
|
8 (9)
|
8 (10)
|
8 (7.5)
|
8 (9)
|
7 (8)
|
7 (9)
|
7 (7)
|
6 (6)
|
6 (6)
|
7 (8)
|
|
IHM, n (%)
|
25 (5.9)
|
38 (7.93)
|
40 (6.79)
|
49 (7.52)
|
62 (8.09)
|
59 (7.07)
|
69 (6.17)
|
89 (7.08)
|
87 (6.52)
|
83 (6.02)
|
601 (6.80)
|
|
Diabetes
|
|
N
|
51
|
63
|
86
|
104
|
109
|
166
|
209
|
262
|
258
|
243
|
1551
|
|
Incidence*
|
2.14
|
2.64
|
3.46
|
4.02
|
4.21
|
5.88
|
7.06
|
8.85
|
7.66
|
7.21
|
5.55
|
|
Age, mean* (SD)
|
72.88 (6.51)
|
72.37 (7.79)
|
72.36 (7.21)
|
73.7 (6.61)
|
72.39 (7.52)
|
72.82 (7.54)
|
73.24 (7.23)
|
72.98 (7.34)
|
73.69 (7.65)
|
73.16 (7.65)
|
73.09 (7.39)
|
|
Male, n (%)
|
49 (96.08)
|
59 (93.65)
|
86
|
103 (99.04)
|
104 (95.41)
|
161 (96.99)
|
203 (97.13)
|
257 (98.09)
|
247 (95.74)
|
233 (95.88)
|
1502 (96.84)
|
|
CCI 0–1, n (%)*
|
21 (41.18)
|
21 (33.33)
|
41 (47.67)
|
41 (39.42)
|
47 (43.12)
|
70 (42.17)
|
89 (42.58)
|
138 (52.67)
|
124 (48.06)
|
130 (53.5)
|
722 (46.55)
|
|
CCI 2, n (%)
|
26 (50.98)
|
30 (47.62)
|
28 (32.56)
|
42 (40.38)
|
38 (34.86)
|
59 (35.54)
|
91 (43.54)
|
95 (36.26)
|
97 (37.6)
|
75 (30.86)
|
581 (37.46)
|
|
CCI ≥3, n (%)
|
4 (7.84)
|
12 (19.05)
|
17 (19.77)
|
21 (20.19)
|
24 (22.02)
|
37 (22.29)
|
29 (13.88)
|
29 (11.07)
|
37 (14.34)
|
38 (15.64)
|
248 (15.99)
|
|
Smoking*
|
18 (35.29)
|
33 (52.38)
|
34 (39.53)
|
37 (35.58)
|
34 (31.19)
|
59 (35.54)
|
100 (47.85)
|
120 (45.8)
|
109 (42.25)
|
106 (43.62)
|
650 (41.91)
|
|
LOSH, mean (SD)
|
9 (8)
|
7 (7)
|
8 (7)
|
7 (8)
|
8 (12)
|
7 (6)
|
7 (6)
|
7 (8)
|
7 (7)
|
6 (6)
|
7 (7)
|
|
IHM, n (%)
|
3 (5.88)
|
6 (9.52)
|
3 (3.49)
|
9 (8.65)
|
9 (8.26)
|
11 (6.63)
|
12 (5.74)
|
11 (4.2)
|
15 (5.81)
|
12 (4.94)
|
91 (5.87)
|
- N: Number of procedures; Incidence: per 100,000 inhabitants; LOHS: length of stay; IHM: In-hospital mortality; CCI (Charlson Comorbidity Index): Comorbidities included in the Charlson comorbidity index, except diabetes.*P < 0.05 (ANOVA or Kruskal-Wallis analysis) or (χ2 linear trend analysis).
